- Home
- AGI vs RGEN Comparison
AGI vs RGEN Comparison
Compare AGI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- RGEN
- Stock Information
- Founded
- AGI 2003
- RGEN 1981
- Country
- AGI Canada
- RGEN United States
- Employees
- AGI N/A
- RGEN N/A
- Industry
- AGI Precious Metals
- RGEN Medical/Dental Instruments
- Sector
- AGI Basic Materials
- RGEN Health Care
- Exchange
- AGI Nasdaq
- RGEN Nasdaq
- Market Cap
- AGI 10.8B
- RGEN 8.0B
- IPO Year
- AGI 1999
- RGEN N/A
- Fundamental
- Price
- AGI $24.77
- RGEN $131.48
- Analyst Decision
- AGI Buy
- RGEN Buy
- Analyst Count
- AGI 4
- RGEN 12
- Target Price
- AGI $30.38
- RGEN $172.67
- AVG Volume (30 Days)
- AGI 4.4M
- RGEN 860.3K
- Earning Date
- AGI 04-30-2025
- RGEN 04-29-2025
- Dividend Yield
- AGI 0.37%
- RGEN N/A
- EPS Growth
- AGI 19.70
- RGEN N/A
- EPS
- AGI 0.62
- RGEN N/A
- Revenue
- AGI $1,402,300,000.00
- RGEN $650,429,000.00
- Revenue This Year
- AGI $26.44
- RGEN $12.61
- Revenue Next Year
- AGI $10.10
- RGEN $15.24
- P/E Ratio
- AGI $44.22
- RGEN N/A
- Revenue Growth
- AGI 33.63
- RGEN 4.88
- 52 Week Low
- AGI $15.01
- RGEN $102.97
- 52 Week High
- AGI $31.00
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- AGI 41.51
- RGEN 43.26
- Support Level
- AGI $26.41
- RGEN $123.10
- Resistance Level
- AGI $27.15
- RGEN $143.56
- Average True Range (ATR)
- AGI 0.93
- RGEN 6.86
- MACD
- AGI -0.33
- RGEN -1.26
- Stochastic Oscillator
- AGI 27.49
- RGEN 14.24
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.